Monday, October 24, 2016
Stellar Biotechnologies Names VP
Los Angeles-based Stellar Biotechnologies, a developer of an immune stimulating protein for the therapeutic market, has named Gregory T. Baxter, Ph.D., as Executive Vice President of Corporate Development. Baxter was most recently Senior Scientist in the Department of Clinical Drug Development for CCS Associates, Inc. , and also has been Adjunct Associate Professor at Cornell University in the College of Chemical Engineering and on the Founders Board of Stanford University's StartX Med Program. He also has founded Hurel Corporation, Aegen Biosciences, and served at Molecular Devices Corporation. Stellar Biotechnologies is based in Port Hueneme.